Derek M. Meisner - 23 Jun 2021 Form 4 Insider Report for X4 Pharmaceuticals, Inc (XFOR)

Signature
/s/ Derek M. Meisner
Issuer symbol
XFOR
Transactions as of
23 Jun 2021
Net transactions value
-$29,162
Form type
4
Filing time
25 Jun 2021, 16:03:25 UTC
Previous filing
17 Jun 2021
Next filing
19 Aug 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction XFOR Common Stock Award $0 +12,500 +17% $0.000000 85,228 23 Jun 2021 Direct F1
transaction XFOR Common Stock Sale $29,162 -4,166 -4.9% $7.00* 81,062 24 Jun 2021 Direct F2, F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock units issued to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer and has no expiration date. One third of the shares underlying the restricted stock unit award vested on June 23, 2021. One third of the shares will vest on June 23, 2022, and one third of the shares will vest on June 23, 2023, subject to the Reporting Person providing continuous service to the Issuer on such dates. Shares in respect of the vested portion of the award must be delivered no later than March 15 of the calendar year following the year in which vesting occurs.
F2 The reported transaction was effected pursuant to a Rule 10b5-1 trading plan.
F3 The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $6.86 to $7.28, inclusive. The Reporting Person undertakes to provide the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
F4 Represents unvested restricted stock units.